Developer docs
API playgroundTry for free, no card

Search company profiles

The University of Texas Medical Branch

Full company profile

uuid0003rdm

Namestring
The University of Texas Medical Branch
Legal namestring
The University of Texas Medical Branch
Websiteurl
utmb.edu
Company typeenum
Private
Founded yearint
1891
Descriptiontext

The University of Texas Medical Branch (UTMB) is a state-funded academic medical center and component of the University of Texas System, founded in 1891 in Galveston, Texas, operating an integrated enterprise spanning patient care, medical education, and biomedical research. The health system runs four hospital campuses totaling 1,123 beds (Galveston 777, Clear Lake 192, League City 97, Angleton Danbury 57) supported by 117 outpatient clinics and a telemedicine service that logged 146,811 encounters in FY2025; clinical volumes included 1,659,838 outpatient visits, 147,806 ED visits, and 45,261 discharges. Educational operations span five schools (John Sealy School of Medicine, Graduate School of Biomedical Sciences, School of Nursing, School of Health Professions, and School of Public and Population Health) enrolling 3,604 students, supported by 1,209 faculty members.

Revenue is generated through diversified streams: net patient care ($2.52B FY2025), state appropriations ($418.9M), grants and contracts ($354.9M including 141 NIH grants worth $89.2M), endowment investment activity ($194.9M against an $851.3M endowment base), tuition and fees ($50.0M), gifts and sponsored programs ($55.5M), and technology licensing ($2.4M from 8 licenses/options and 19 issued US patents). Total FY2025 revenue reached approximately $3.80B against an annual operating budget exceeding $3.6B. The Office of Innovation and Technology Transfer manages IP commercialization through patent prosecution, licensing, and material transfer agreements.

UTMB has built an AI-enabled clinical technology stack spanning generative AI (Qualified Health platform powered by Anthropic Claude for medical record analysis and care gap identification, live in cardiology with planned systemwide expansion by end of 2026), computer vision (Aidoc for neurovascular triage, Bunkerhill Health for cardiac CT screening, NIPOKA PEMP for kidney biopsy analysis using 3D super-resolution microscopy), anomaly detection (Viz.ai ECG screening for hypertrophic cardiomyopathy), and ambient clinical NLP (Microsoft Dragon Copilot, Open Evidence). An institutional AI Council led by inaugural Chief AI Officer Dr. Peter McCaffrey governs deployment. CMS established new billing code G0680 at $15.50 per scan for AI-enabled cardiac screening, a regulatory outcome UTMB helped originate through its Bunkerhill partnership. The institution also leads biodefense vaccine research, with the HDT-321 CCHF vaccine advancing to FDA-cleared Phase 1 trials.

Short descriptiontext

The University of Texas Medical Branch is a public academic medical center in Galveston, Texas, operating four hospital campuses, 117 clinics, and five schools, serving 1.6M+ outpatient visits annually through integrated patient care, medical education, and AI-enabled biomedical research.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersGalveston, United States
HQ citystring
Galveston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
academic medical center, medical education, healthcare services, biomedical research, hospital services
Industry4 codes
1Academic Medical Centers (AMCs) & Teaching Hospitals
CodeHLAFAAAAPrimaryYes
2Academic Medical Centers & Teaching Hospitals (University-Affiliated)
CodeEDAHAGAAPrimaryNo
3Medical Schools (MD/DO Granting)
CodeEDAHAGABPrimaryNo
4Public Research Universities with Academic Medical Centers (AMCs)
CodeEDAHAAACPrimaryNo
NAICS code3 codes
  • General Medical and Surgical Hospitals6221
  • Colleges, Universities, and Professional Schools6113
  • Scientific Research and Development Services5417
SIC code2 codes
  • Services-General Medical & Surgical Hospitals, Nec8062
  • Services-Hospitals8060
Product category
Academic Medical Center
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model7 records
1Net Patient Care Revenue
TypeSubscription Recurring
Description

Revenue from hospital and clinic services across UTMB Health System including four hospital campuses and 117 clinics. FY2025: $2,522,492 thousand. Includes unsponsored care of $299.4 million.

utmb.edu
2Grants and Contracts
TypeTransaction Fee
Description

Federal and non-federal research funding including NIH awards. FY2025: $354,943 thousand. Includes NIH dollars of $89.2 million with 141 NIH grants.

utmb.edu
3State Appropriations
TypeSubscription Recurring
Description

State of Texas funding for medical education and public service mission. FY2025: $418,923 thousand.

utmb.edu
4Net Tuition and Fees
TypeSubscription Recurring
Description

Revenue from educational programs across five schools. FY2025: $50,015 thousand.

utmb.edu
5Gifts and Sponsored Programs
TypeTransaction Fee
Description

Private donations, sponsored programs for capital acquisitions, and endowment additions. FY2025: $55,461 thousand.

utmb.edu
6Investment Activity
TypeData Monetisation
Description

Endowment investment returns and market value adjustments. FY2025: $194,925 thousand. Total endowments: $851.3 million.

utmb.edu
7Technology Licensing
TypeLicensing Royalties
Description

Revenue from licensing UTMB technologies. FY2025: $2.4 million from 8 licenses/options. Invention disclosures: 45. US Patents issued: 19.

utmb.edu
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
Pricing details2 tiers
1Pharmacogenomic (PGx) Testing - Cash pay
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Cash cost: $499. Many benefit plans do not cover the test. Payment plans available through PayZen with no credit score requirement.

utmb.edu
2AI-enabled coronary artery calcium analysis (CMS G0680)
ModelSubscriptionBilling cadencePay-as-you-go
Notes

CMS established national billing code G0680 with $15.50 payment rate for AI-enabled algorithmic analysis of coronary artery calcium and aortic valve calcium on chest CT scans.

fiercehealthcare.com
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 of 2 records shown
1UTMB Health
Description

The health system brand for The University of Texas Medical Branch providing patient care services

utmb.edu
+1 more record
Core offering1 text field

The University of Texas Medical Branch (UTMB) operates an integrated academic medical center delivering patient care across four hospital campuses (1,123 beds) and 117 outpatient clinics, medical and health professions education across five schools (Medicine, Nursing, Health Professions, Graduate School of Biomedical Sciences, and Public and Population Health), and biomedical research with $188 million in sponsored research expenditures. It also conducts AI-enabled clinical innovation, technology licensing, and community population health programs across Southeast Texas.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 91% reduction in composite complications during spinal cord stimulator implantation procedures using CompuFlo technology
+2 more records
Product overview1 text field

The University of Texas Medical Branch (UTMB) operates as an academic medical center with a diversified portfolio of healthcare, education, research, and innovation services. The institution has established a formal AI governance structure through its AI Council led by the Chief AI Officer, Dr. Peter McCaffrey. UTMB's technology offerings include multiple AI-powered clinical tools: the Qualified Health AI Platform (using Anthropic Claude models) for medical record analysis and care gap identification; Bunkerhill Health AI for cardiac screening from CT scans; Viz.ai Viz HCM for ECG-based hypertrophic cardiomyopathy detection; Aidoc Neuro AI for intracranial hemorrhage detection; Open Evidence for medical literature access; and NIPOKA PEMP for AI-enhanced kidney diagnostics. Supporting infrastructure includes UTMB Co-Pilot for administrative reporting, Microsoft Dragon Copilot for clinical dictation, and Microsoft Teams Premium for AI-enabled meeting notes. UTMB also operates the Diagnostic Center offering AI-supported diagnostic consultation services, and partners on the Blue Zones Project for population health improvement. The institution's technology stack includes various AI integrations and platforms designed to enhance clinical decision-making, operational efficiency, and patient outcomes across its health system serving Southeast Texas.

Product and service13 records
1UTMB Health System Patient Care Services
CategoryHealthcare Services
Description

Inpatient and outpatient care delivered across four hospital campuses (Galveston, Clear Lake, League City, Angleton Danbury) totaling 1,123 beds and 117 clinics, with 1.66 million outpatient encounters, 45,261 discharges, and 147,806 ED visits annually for patients across Southeast Texas.

2Medical Degree (MD) Program
CategoryMedical Education
Description

Four-year MD degree program through the John Sealy School of Medicine with 941 enrolled medical students, including global opportunities and pioneering research experiences.

3School of Nursing Degree Programs
CategoryMedical Education
Description

BSN, MSN, and DNP nursing degree programs with 1,314 total enrollment, preparing students for clinical nursing careers and advanced practice roles.

4Graduate School of Biomedical Sciences Programs
CategoryMedical Education
Description

PhD and postdoctoral research training in biomedical sciences with 282 enrolled students, supporting laboratory-based research careers.

5School of Health Professions Programs
CategoryMedical Education
Description

Allied health degree programs including Physical Therapy, Occupational Therapy, and Physician Assistant Studies with 750 students across various programs.

6School of Public and Population Health Programs
CategoryMedical Education
Description

MPH and doctoral programs in public and population health with 127 students enrolled.

7Biomedical Research Services
CategoryResearch Services
Description

Funded biomedical and clinical research program delivering $188 million in sponsored research expenditures annually, including 141 NIH grants and $89.2 million in NIH funding.

8Technology Licensing and Transfer
CategoryTechnology Licensing
Description

Office of Innovation and Technology Transfer licensing UTMB-originated technologies to industry partners, with 19 US patents issued in FY2025, 8 licenses/options executed, and $2.4 million in licensing revenue.

9UTMB Telemedicine Services
CategoryHealthcare Services
Description

Virtual care services delivering 146,811 telemedicine encounters annually to patients across Southeast Texas.

10Qualified Health AI Platform
CategoryAI Healthcare Platform
Description

Generative AI system analyzing millions of medical records to identify patients qualifying for guideline-recommended care, with productivity agents, clinical quality registries, and care gap identification tools.

11NIPOKA PEMP Kidney Diagnostic Technology
CategoryAI Diagnostic Technology
Description

Podocyte Exact Morphology Measurement Procedure combining immunofluorescence staining, 3D super-resolution microscopy, and proprietary AI software for earlier kidney disease detection through analysis of kidney biopsies.

12Bunkerhill Health AI Cardiac Screening
CategoryAI Diagnostic Technology
Description

AI algorithms analyzing routine chest CT scans to identify patients with cardiovascular risk and unaddressed coronary artery calcium, with 11.7% of screened patients identified as at risk.

13Viz.ai Viz HCM ECG Screening
Scale indicator19 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-01
Description

IAVI announced an agreement with UTMB to develop a recombinant vesicular stomatitis virus-based vaccine candidate targeting Bundibugyo virus. CEPI awarded IAVI $3.2 million to accelerate early development. The candidate demonstrated protective efficacy in nonhuman primate studies.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-05-21
Description

UTMB received MCDC Innovation Prototype Award for advancing Crimean-Congo hemorrhagic fever (CCHF) vaccine candidate HDT-321 from lab to Phase 1 clinical trial. Vaccine received FDA clearance with ongoing Phase 1 trial.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-05-15
Description

Collaboration on research discovering how ATR enzyme protects DNA during cell replication, with potential impact on cancer drug development.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-20
Description

Partnership to launch Blue Zones Project in Galveston, Texas with a nine-month foundation phase focused on community engagement and infrastructure building. Multi-year initiative to improve community well-being by shaping environments to make healthy choices easier.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-01-21
Description

Landmark AI deployment using Claude AI models to analyze millions of medical records and identify patients qualifying for guideline-recommended care. Live at UTMB focusing initially on cardiology care, expanding systemwide by end of 2026.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-12-08
Description

Strategic partnership bringing NIPOKA's Podocyte Exact Morphology Measurement Procedure (PEMP) technology to UTMB. First in world clinical application of groundbreaking kidney diagnostic technology. Supported by $4 million commitment from Sealy & Smith Foundation over four years.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-12-08
Description

Research Collaboration Agreement to advance respiratory products and technology innovations. Includes fluidIQ's HOPE inVent miniature in-line resuscitator technology. Researchers from UTMB co-authored publication in Journal of Anesthesiology's Images in Anesthesiology.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-10-29
Description

Texas Collaborative Prematurity Research Center partnership involving UTMB and UT Southwestern. Initiative uses AI and pregnancy-on-a-chip technology to study and develop treatments for preterm birth.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Public university-affiliated academic health center combining UF Health Science Center, medical school, nursing, pharmacy, and public health schools with hospital operations. Directly comparable as a state-supported multi-school AMC with research and AI-driven care programs.

TypeDirect peer
Description

Private nonprofit medical school and health sciences university located in Houston's Texas Medical Center. Comparable as a high-volume AMC and medical school with strong NIH research funding and extensive clinical affiliations, competing for faculty and patients in the same Gulf Coast region.

TypeEmerging player
Description

Private medical school and health sciences university focused on tropical medicine, biodefense, and public health — overlapping with UTMB's signature biodefense and tropical disease research franchises. Comparable in mission and research niches though smaller in scale.

TypeDirect peer
Description

Private research university medical school paired with Emory Healthcare hospital system. Comparable to UTMB as a multi-specialty AMC operator with significant NIH research, AI/health informatics investments, and a similar multi-school academic structure.

TypeDirect peer
Description

Private nonprofit academic medical center with integrated health system, medical school, and substantial NIH-funded research portfolio. Comparable in scope (multi-school, hospital + clinics, AI-driven clinical initiatives) and a benchmark for translation research and clinical informatics.

TypeDirect peer
Description

Private university academic medical center with medical school (Miller School of Medicine), teaching hospitals, and significant NIH-funded research. Comparable to UTMB in operating an integrated academic health system and serving a defined regional population.

TypeDirect peer
Description

Public University of Texas System academic medical center in Dallas, operating patient care, medical education (UT Southwestern Medical School), and NIH-funded research at similar scale to UTMB. Directly comparable as a public Texas AMC with teaching hospital, medical school, and graduate research programs.

TypeBroad incumbent
Description

Large Houston-based hospital system with extensive specialty care and academic affiliations. Competes directly with UTMB for patients and physicians in the Gulf Coast region and operates as a broader incumbent across the same clinical service lines.

TypeDirect peer
Description

Public UT System health science center with medical, nursing, dental, and health professions schools plus a teaching hospital and research enterprise. Mirrors UTMB's multi-school structure and UT System affiliation, making it a directly comparable peer AMC.

TypeOthers
Description

Nonprofit research collaborator co-located with UTMB in the Texas Collaborative Prematurity Research Center. Included as an ecosystem peer rather than a direct competitor — reflects UTMB's role as a translational research site for collaborative, grant-funded initiatives.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration10 records

Each record includes

Title, Type, Description, Source

AI capability14 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles15 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

The University of Texas Medical Branch

Academic Medical Centerutmb.edu

The University of Texas Medical Branch is a public academic medical center in Galveston, Texas, operating four hospital campuses, 117 clinics, and five schools, serving 1.6M+ outpatient visits annually through integrated patient care, medical education, and AI-enabled biomedical research.

What The University of Texas Medical Branch does

The University of Texas Medical Branch (UTMB) is a state-funded academic medical center and component of the University of Texas System, founded in 1891 in Galveston, Texas, operating an integrated enterprise spanning patient care, medical education, and biomedical research. The health system runs four hospital campuses totaling 1,123 beds (Galveston 777, Clear Lake 192, League City 97, Angleton Danbury 57) supported by 117 outpatient clinics and a telemedicine service that logged 146,811 encounters in FY2025; clinical volumes included 1,659,838 outpatient visits, 147,806 ED visits, and 45,261 discharges. Educational operations span five schools (John Sealy School of Medicine, Graduate School of Biomedical Sciences, School of Nursing, School of Health Professions, and School of Public and Population Health) enrolling 3,604 students, supported by 1,209 faculty members.

Revenue is generated through diversified streams: net patient care ($2.52B FY2025), state appropriations ($418.9M), grants and contracts ($354.9M including 141 NIH grants worth $89.2M), endowment investment activity ($194.9M against an $851.3M endowment base), tuition and fees ($50.0M), gifts and sponsored programs ($55.5M), and technology licensing ($2.4M from 8 licenses/options and 19 issued US patents). Total FY2025 revenue reached approximately $3.80B against an annual operating budget exceeding $3.6B. The Office of Innovation and Technology Transfer manages IP commercialization through patent prosecution, licensing, and material transfer agreements.

UTMB has built an AI-enabled clinical technology stack spanning generative AI (Qualified Health platform powered by Anthropic Claude for medical record analysis and care gap identification, live in cardiology with planned systemwide expansion by end of 2026), computer vision (Aidoc for neurovascular triage, Bunkerhill Health for cardiac CT screening, NIPOKA PEMP for kidney biopsy analysis using 3D super-resolution microscopy), anomaly detection (Viz.ai ECG screening for hypertrophic cardiomyopathy), and ambient clinical NLP (Microsoft Dragon Copilot, Open Evidence). An institutional AI Council led by inaugural Chief AI Officer Dr. Peter McCaffrey governs deployment. CMS established new billing code G0680 at $15.50 per scan for AI-enabled cardiac screening, a regulatory outcome UTMB helped originate through its Bunkerhill partnership. The institution also leads biodefense vaccine research, with the HDT-321 CCHF vaccine advancing to FDA-cleared Phase 1 trials.

The University of Texas Medical Branch firmographics

Firmographics
Name
The University of Texas Medical Branch
Legal name
The University of Texas Medical Branch
Website
https://utmb.edu
Company type
Private
Founded year
1891
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
The University of Texas Medical Branch is a public academic medical center in Galveston, Texas, operating four hospital campuses, 117 clinics, and five schools, serving 1.6M+ outpatient visits annually through integrated patient care, medical education, and AI-enabled biomedical research.
Ownership category
akta.pro rank

The University of Texas Medical Branch industry classification

Industry
Product category
Academic Medical Center
NAICS
General Medical and Surgical Hospitals (6221), Colleges, Universities, and Professional Schools (6113), Scientific Research and Development Services (5417)
SIC
Services-General Medical & Surgical Hospitals, Nec (8062), Services-Hospitals (8060)
akta.pro primary industry
Academic Medical Centers (AMCs) & Teaching Hospitals (HLAFAAAA)
akta.pro secondary industries
Academic Medical Centers & Teaching Hospitals (University-Affiliated) (EDAHAGAA), Medical Schools (MD/DO Granting) (EDAHAGAB), Public Research Universities with Academic Medical Centers (AMCs) (EDAHAAAC)

Keywords

  • Academic medical center
  • Medical education
  • Healthcare services
  • Biomedical research
  • Hospital services

Where The University of Texas Medical Branch is headquartered

Location

Headquarters

HQ city
Galveston
HQ country
United States
HQ region
North America

Offices4 records

Markets served

The University of Texas Medical Branch business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

  1. Net Patient Care Revenue: Revenue from hospital and clinic services across UTMB Health System including four hospital campuses and 117 clinics. FY2025: $2,522,492 thousand. Includes unsponsored care of $299.4 million.
  2. Grants and Contracts: Federal and non-federal research funding including NIH awards. FY2025: $354,943 thousand. Includes NIH dollars of $89.2 million with 141 NIH grants.
  3. State Appropriations: State of Texas funding for medical education and public service mission. FY2025: $418,923 thousand.
  4. Net Tuition and Fees: Revenue from educational programs across five schools. FY2025: $50,015 thousand.
  5. Gifts and Sponsored Programs: Private donations, sponsored programs for capital acquisitions, and endowment additions. FY2025: $55,461 thousand.
  6. Investment Activity: Endowment investment returns and market value adjustments. FY2025: $194,925 thousand. Total endowments: $851.3 million.
  7. Technology Licensing: Revenue from licensing UTMB technologies. FY2025: $2.4 million from 8 licenses/options. Invention disclosures: 45. US Patents issued: 19.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goPharmacogenomic (PGx) Testing - Cash pay
SubscriptionPay-as-you-goAI-enabled coronary artery calcium analysis (CMS G0680)

Go-to-market motion1 record

Distribution channels6 records

Marketing channels5 records

The University of Texas Medical Branch product offering

Product offering

Core offering

The University of Texas Medical Branch (UTMB) operates an integrated academic medical center delivering patient care across four hospital campuses (1,123 beds) and 117 outpatient clinics, medical and health professions education across five schools (Medicine, Nursing, Health Professions, Graduate School of Biomedical Sciences, and Public and Population Health), and biomedical research with $188 million in sponsored research expenditures. It also conducts AI-enabled clinical innovation, technology licensing, and community population health programs across Southeast Texas.

Product overview

The University of Texas Medical Branch (UTMB) operates as an academic medical center with a diversified portfolio of healthcare, education, research, and innovation services. The institution has established a formal AI governance structure through its AI Council led by the Chief AI Officer, Dr. Peter McCaffrey. UTMB's technology offerings include multiple AI-powered clinical tools: the Qualified Health AI Platform (using Anthropic Claude models) for medical record analysis and care gap identification; Bunkerhill Health AI for cardiac screening from CT scans; Viz.ai Viz HCM for ECG-based hypertrophic cardiomyopathy detection; Aidoc Neuro AI for intracranial hemorrhage detection; Open Evidence for medical literature access; and NIPOKA PEMP for AI-enhanced kidney diagnostics. Supporting infrastructure includes UTMB Co-Pilot for administrative reporting, Microsoft Dragon Copilot for clinical dictation, and Microsoft Teams Premium for AI-enabled meeting notes. UTMB also operates the Diagnostic Center offering AI-supported diagnostic consultation services, and partners on the Blue Zones Project for population health improvement. The institution's technology stack includes various AI integrations and platforms designed to enhance clinical decision-making, operational efficiency, and patient outcomes across its health system serving Southeast Texas.

Differentiator

Problem solved

Functional benefit

Brands

  • UTMB Health: The health system brand for The University of Texas Medical Branch providing patient care services
  • UTMB Health System

Products and services

  • UTMB Health System Patient Care Services Inpatient and outpatient care delivered across four hospital campuses (Galveston, Clear Lake, League City, Angleton Danbury) totaling 1,123 beds and 117 clinics, with 1.66 million outpatient encounters, 45,261 discharges, and 147,806 ED visits annually for patients across Southeast Texas.
  • Medical Degree (MD) Program Four-year MD degree program through the John Sealy School of Medicine with 941 enrolled medical students, including global opportunities and pioneering research experiences.
  • School of Nursing Degree Programs BSN, MSN, and DNP nursing degree programs with 1,314 total enrollment, preparing students for clinical nursing careers and advanced practice roles.
  • Graduate School of Biomedical Sciences Programs PhD and postdoctoral research training in biomedical sciences with 282 enrolled students, supporting laboratory-based research careers.
  • School of Health Professions Programs Allied health degree programs including Physical Therapy, Occupational Therapy, and Physician Assistant Studies with 750 students across various programs.
  • School of Public and Population Health Programs MPH and doctoral programs in public and population health with 127 students enrolled.
  • Biomedical Research Services Funded biomedical and clinical research program delivering $188 million in sponsored research expenditures annually, including 141 NIH grants and $89.2 million in NIH funding.
  • Technology Licensing and Transfer Office of Innovation and Technology Transfer licensing UTMB-originated technologies to industry partners, with 19 US patents issued in FY2025, 8 licenses/options executed, and $2.4 million in licensing revenue.
  • UTMB Telemedicine Services Virtual care services delivering 146,811 telemedicine encounters annually to patients across Southeast Texas.
  • Qualified Health AI Platform Generative AI system analyzing millions of medical records to identify patients qualifying for guideline-recommended care, with productivity agents, clinical quality registries, and care gap identification tools.
  • NIPOKA PEMP Kidney Diagnostic Technology Podocyte Exact Morphology Measurement Procedure combining immunofluorescence staining, 3D super-resolution microscopy, and proprietary AI software for earlier kidney disease detection through analysis of kidney biopsies.
  • Bunkerhill Health AI Cardiac Screening AI algorithms analyzing routine chest CT scans to identify patients with cardiovascular risk and unaddressed coronary artery calcium, with 11.7% of screened patients identified as at risk.
  • Viz.ai Viz HCM ECG Screening

Quantifiable outcome

  • 91% reduction in composite complications during spinal cord stimulator implantation procedures using CompuFlo technology
  • +2 more outcomes

Companies that use The University of Texas Medical Branch

Customer profile

Named customers1 record

Segments7 records

Ideal customer profiles5 records

The University of Texas Medical Branch technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration10 records

AI capability14 records

Feature7 records

The University of Texas Medical Branch partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and minor.

  • IAVIcoreStrategic or Co-development Partner · 1 June 2026IAVI announced an agreement with UTMB to develop a recombinant vesicular stomatitis virus-based vaccine candidate targeting Bundibugyo virus. CEPI awarded IAVI $3.2 million to accelerate early development. The candidate demonstrated protective efficacy in nonhuman primate studies.
  • HDT BiominorStrategic or Co-development Partner · 21 May 2026UTMB received MCDC Innovation Prototype Award for advancing Crimean-Congo hemorrhagic fever (CCHF) vaccine candidate HDT-321 from lab to Phase 1 clinical trial. Vaccine received FDA clearance with ongoing Phase 1 trial.
  • Research PartnersminorStrategic or Co-development Partner · 15 May 2026Collaboration on research discovering how ATR enzyme protects DNA during cell replication, with potential impact on cancer drug development.
  • Blue ZonescoreStrategic or Co-development Partner · 20 February 2026Partnership to launch Blue Zones Project in Galveston, Texas with a nine-month foundation phase focused on community engagement and infrastructure building. Multi-year initiative to improve community well-being by shaping environments to make healthy choices easier.
  • Qualified Health and AnthropiccoreTechnology or Integration · 21 January 2026Landmark AI deployment using Claude AI models to analyze millions of medical records and identify patients qualifying for guideline-recommended care. Live at UTMB focusing initially on cardiology care, expanding systemwide by end of 2026.
  • NIPOKA GmbHcoreTechnology or Integration · 8 December 2025Strategic partnership bringing NIPOKA's Podocyte Exact Morphology Measurement Procedure (PEMP) technology to UTMB. First in world clinical application of groundbreaking kidney diagnostic technology. Supported by $4 million commitment from Sealy & Smith Foundation over four years.
  • fluidIQminorStrategic or Co-development Partner · 8 December 2025Research Collaboration Agreement to advance respiratory products and technology innovations. Includes fluidIQ's HOPE inVent miniature in-line resuscitator technology. Researchers from UTMB co-authored publication in Journal of Anesthesiology's Images in Anesthesiology.
  • March of DimesminorStrategic or Co-development Partner · 29 October 2025Texas Collaborative Prematurity Research Center partnership involving UTMB and UT Southwestern. Initiative uses AI and pregnancy-on-a-chip technology to study and develop treatments for preterm birth.

Scale indicators19 records

Recent moves6 records

Expansion highlights7 records

The University of Texas Medical Branch competitors and assessment

Company assessment

Direct peers

  • University of Florida Health: Public university-affiliated academic health center combining UF Health Science Center, medical school, nursing, pharmacy, and public health schools with hospital operations. Directly comparable as a state-supported multi-school AMC with research and AI-driven care programs.
  • Baylor College of Medicine: Private nonprofit medical school and health sciences university located in Houston's Texas Medical Center. Comparable as a high-volume AMC and medical school with strong NIH research funding and extensive clinical affiliations, competing for faculty and patients in the same Gulf Coast region.
  • Emory University School of Medicine: Private research university medical school paired with Emory Healthcare hospital system. Comparable to UTMB as a multi-specialty AMC operator with significant NIH research, AI/health informatics investments, and a similar multi-school academic structure.
  • Vanderbilt University Medical Center: Private nonprofit academic medical center with integrated health system, medical school, and substantial NIH-funded research portfolio. Comparable in scope (multi-school, hospital + clinics, AI-driven clinical initiatives) and a benchmark for translation research and clinical informatics.
  • University of Miami Health System: Private university academic medical center with medical school (Miller School of Medicine), teaching hospitals, and significant NIH-funded research. Comparable to UTMB in operating an integrated academic health system and serving a defined regional population.
  • UT Southwestern Medical Center: Public University of Texas System academic medical center in Dallas, operating patient care, medical education (UT Southwestern Medical School), and NIH-funded research at similar scale to UTMB. Directly comparable as a public Texas AMC with teaching hospital, medical school, and graduate research programs.
  • UT Health San Antonio: Public UT System health science center with medical, nursing, dental, and health professions schools plus a teaching hospital and research enterprise. Mirrors UTMB's multi-school structure and UT System affiliation, making it a directly comparable peer AMC.

Emerging players

  • Tulane University School of Medicine: Private medical school and health sciences university focused on tropical medicine, biodefense, and public health — overlapping with UTMB's signature biodefense and tropical disease research franchises. Comparable in mission and research niches though smaller in scale.

Broad incumbents

  • Houston Methodist: Large Houston-based hospital system with extensive specialty care and academic affiliations. Competes directly with UTMB for patients and physicians in the Gulf Coast region and operates as a broader incumbent across the same clinical service lines.

Others

  • March of Dimes Prematurity Research Center: Nonprofit research collaborator co-located with UTMB in the Texas Collaborative Prematurity Research Center. Included as an ecosystem peer rather than a direct competitor — reflects UTMB's role as a translational research site for collaborative, grant-funded initiatives.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

The University of Texas Medical Branch social profiles

Digital presence

The University of Texas Medical Branch compliance and trust

Trust signal

Compliance2 records

The University of Texas Medical Branch financial estimates

Financial estimate

Revenue estimate

Valuation estimate

The University of Texas Medical Branch leadership team

Management profile

Number of profiles

Profiles15 records

The University of Texas Medical Branch funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

The University of Texas Medical Branch M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The University of Texas Medical Branch

What does The University of Texas Medical Branch do?

The University of Texas Medical Branch (UTMB) operates an integrated academic medical center delivering patient care across four hospital campuses (1,123 beds) and 117 outpatient clinics, medical and health professions education across five schools (Medicine, Nursing, Health Professions, Graduate School of Biomedical Sciences, and Public and Population Health), and biomedical research with $188 million in sponsored research expenditures. It also conducts AI-enabled clinical innovation, technology licensing, and community population health programs across Southeast Texas.

Is The University of Texas Medical Branch a public or private company?

The University of Texas Medical Branch is a private company. It is classified as state government owned and is currently operating.

When was The University of Texas Medical Branch founded?

The University of Texas Medical Branch was founded in 1891. It employs 5,001 to 10,000 people.

Where is The University of Texas Medical Branch based?

The University of Texas Medical Branch is headquartered in Galveston, United States, in the North America region.

How does The University of Texas Medical Branch make money?

Seven revenue lines are on record. Net Patient Care Revenue is the primary driver. The others are grants and Contracts, state Appropriations, net Tuition and Fees, gifts and Sponsored Programs, investment Activity and technology Licensing.

Who are The University of Texas Medical Branch's main competitors?

Direct peers on record are University of Florida Health, Baylor College of Medicine, Emory University School of Medicine, Vanderbilt University Medical Center, University of Miami Health System, UT Southwestern Medical Center and UT Health San Antonio. Tulane University School of Medicine is listed as an emerging player. Houston Methodist is listed as a broad incumbent. March of Dimes Prematurity Research Center is listed as an others.

Does The University of Texas Medical Branch have an API?

No public API is recorded for The University of Texas Medical Branch.

What industry is The University of Texas Medical Branch in?

The University of Texas Medical Branch's product category is Academic Medical Center. Its primary akta.pro industry code is HLAFAAAA, Academic Medical Centers (AMCs) & Teaching Hospitals, with a secondary code of EDAHAGAA, Academic Medical Centers & Teaching Hospitals (University-Affiliated). Its NAICS code is 6221 and its SIC code is 8062.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
American City Business JournalsHouston colleges by revenue, 2026The University of Texas Medical Branch at Galveston generated $3.68 billion in fall 2024, while UTHealth Houston brought in $2.82 billion. These figures make UTMB the top revenue earner among Houston colleges.Business Wire BlogUniversity of Texas Medical Branch (UTMB) Collaborates with OpenEvidence to Integrate AI Platform Directly Into Clinical WorkflowsUTMB and OpenEvidence integrated an AI platform into clinicians' workflows, going live in March. Over half of UTMB clinicians now use OpenEvidence for clinical decision support, with adoption growing since launch. UTMB will continue evaluating utilization and clinician experience.The Daily NewsUniversity of Texas Medical Branch police earn second law enforcement accreditationThe University of Texas Medical Branch Police Department earned its second law enforcement accreditation from the International Association of Campus Law Enforcement Administrators after an evaluation of its policies, procedures, training, and operations. The department previously held accreditation from the Commission on Accreditation for Law Enforcement Agencies for over a decade.International Business TimesCould GLP-1 Drugs Slow Aging? A New Trial Is Putting the Theory to the TestResearchers at the University of Texas Medical Branch have initiated a clinical trial to determine if the GLP-1 drug tirzepatide can slow biological aging in adults aged 55 to 70. This investigation follows preliminary findings from UC San Diego and Case Western Reserve University suggesting that semaglutide may influence DNA-based aging markers, although these results are not yet conclusive.AbcnewsResearchers looking into whether GLP-1 drugs can help slow agingResearchers at the University of Texas Medical Branch and UC San Diego are conducting clinical trials to determine if GLP-1 drugs like tirzepatide and semaglutide can slow the biological aging process. Early findings from a UC San Diego study indicated that semaglutide usage correlated with changes in DNA-based aging clocks, while the UTMB trial aims to measure improvements in inflammation, cognitive function, and mobility among older adults.American City Business JournalsUTMB lands $180M heart commitment from Sealy & Smith FoundationThe Sealy & Smith Foundation committed $180 million to UTMB (University of Texas Medical Branch) specifically designated for its heart program, representing a record single gift for the medical institution. With this commitment, the foundation's total giving to UTMB surpasses $1.2 billion. The funds are being used to support a major infrastructure overhaul at the medical institution.Clinical Lab ProductsAlveo, UTMB Develop Point-of-Care Lassa Fever Test for West AfricaAlveo Technologies and the University of Texas Medical Branch (UTMB) have formed a partnership to develop point-of-care diagnostics for Lassa fever, targeting deployment in Nigeria and Sierra Leone. The initiative aims to replace weeks-long laboratory processes with real-time pathogen detection to improve outbreak containment and patient management in West Africa. Additionally, the collaboration includes validating the technology's resilience through field testing in Peru and high-containment studies at UTMB.PR NewswireAlveo Technologies Partners with University of Texas Medical Branch (UTMB) to Develop Point-of-Care Diagnostics for Lassa Fever in West AfricaAlveo Technologies announced a strategic partnership with the University of Texas Medical Branch (UTMB) to develop point-of-care diagnostics for Lassa fever in West Africa. The initiative aims to deploy real-time pathogen detection at clinical sites in Nigeria and Sierra Leone to improve outbreak containment and patient management. This collaboration also includes validation initiatives for avian influenza surveillance in Peru and high-containment testing at UTMB's Galveston National Laboratory.Houston ChronicleGulf Coast officials warn against dangerous flea-borne diseaseResearchers at the University of Texas Medical Branch in Galveston published a study in the CDC's Emerging Infectious Disease journal finding that murine typhus, a flea-borne disease caused by Rickettsia bacteria, has established an endemic foothold in Galveston County, Texas. The study identified 149 adult cases between April 2019 and October 2023, with nearly 80% requiring hospitalization, approximately 30% admitted to intensive care, and two deaths reported. The disease, transmitted by fleas infesting opossums and feral cats, remains difficult to diagnose due to symptom overlap with other febrile illnesses, potentially delaying treatment and increasing severity for elderly and immunocompromised patients.BloombergCongo Ebola Outbreak: Scientists Say Bundibugyo Virus May Be Easier to Treat - BloombergScientists studying the Bundibugyo Ebola strain in the Democratic Republic of Congo have found that it may be easier to treat than other strains, as it replicates more slowly than the Zaire strain responsible for the West African epidemic. Researchers at the University of Texas Medical Branch discovered that Bundibugyo causes a slower progression of symptoms, with patients remaining mobile while infectious—a pattern some doctors call "walking Ebola"—which may paradoxically aid treatment intervention. The findings come amid the fastest-growing Ebola outbreak on record in the DRC, where the unique characteristics of this rare strain are being closely monitored by the scientific community.